Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.138,64
0,20%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Krystal Biotech Inc (KRYS) Krystal Biotech Inc (KRYS) Notizie

Krystal Biotech Inc

KRYS
177,78
-4,94 (-2,70%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/6/202400:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
05/6/202413:00GLOBEKrystal Biotech to Present at Goldman Sachs 45th Annual..
21/5/202422:38EDGAR2Form 8-K - Current report
15/5/202413:00GLOBEKrystal Biotech to Present at the American Thoracic Society..
08/5/202413:00GLOBEKrystal Biotech to Present at BofA Securities 2024 Health..
06/5/202414:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202414:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
06/5/202414:04EDGAR2Form 8-K - Current report
06/5/202414:00GLOBEKrystal Biotech Announces First Quarter 2024 Financial..
02/5/202413:00GLOBEKrystal Biotech to Present at the Association for Research..
26/4/202413:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
22/4/202413:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
04/4/202413:00GLOBEKrystal Biotech to Present at the American Association..
02/3/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
26/2/202419:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202414:04EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
26/2/202413:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
20/2/202413:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
13/2/202413:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
08/2/202413:00GLOBEKrystal Biotech Announces Publication in the New England..
01/2/202413:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
24/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202417:43EDGAR2Form 144 - Report of proposed sale of securities
04/1/202413:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
19/12/202313:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
27/11/202313:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
09/11/202313:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
06/11/202313:10EDGAR2Form 8-K - Current report
06/11/202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
30/10/202312:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
02/10/202318:07EDGAR2Form 144 - Report of proposed sale of securities
28/9/202313:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
07/9/202313:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
05/9/202313:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
21/8/202323:30EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:57EDGAR2Form 144 - Report of proposed sale of securities
15/8/202322:56EDGAR2Form 144 - Report of proposed sale of securities
11/8/202322:39EDGAR2Form 144 - Report of proposed sale of securities
11/8/202300:06EDGAR2Form 144 - Report of proposed sale of securities
07/8/202314:18EDGAR2Form 8-K - Current report
07/8/202313:13EDGAR2Form 8-K - Current report
07/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202313:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
Apertura: 180,21 Min: 174,29 Max: 181,25
Chiusura: 182,72

La tua Cronologia

NASDAQ
KRYS
Krystal Biotech
USOTC
PLGDF
Palisades Goldcorp (PK)
EU
CDCKY
CDC Habitat SA 1.3% unti...
USOTC
HEXPF
Angel Wing Metals (PK)
TG
A3LHS4
Booking
EU
CLRAB
Korian 3.74% Coupon due ...
BIT
P1YXA3
NLBNPIT1YXA3 20991231 95...
USOTC
HIBRF
Hibernia REIT (CE)
TG
AF9N
Agence Francaise de Deve...
NASDAQ
FVTHVX
Cboe Vest International ...
BIT
1CLX
Clorox
BIT
F16006
Vontobel Financial Produ...
BIT
F16790
Vontobel Financial Produ...
BIT
P1PWD7
BNP Paribas Issuance
BIT
P1BVR9
BNP Paribas Issuance
BIT
P1OKA1
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network